Literature DB >> 16289896

The early history of myasthenia gravis.

Trevor Hughes1.   

Abstract

Myasthenia gravis was first recognised as a distinct clinical entity by Thomas Willis, a 17th century Oxford physician, whose 1672 account in Latin was largely unnoticed until 1903. The first modern description was made in 1877 by Samuel Wilks, a London physician. Towards the close of the 19th century, primary muscle diseases and diseases due to denervation of muscle were studied by English, French, and German physicians. The first full descriptions of myasthenia gravis were by Wilhelm Erb, of Heidelberg, and Samuel Goldflam of Warsaw. The account by Willis, and the 19th century literature of myasthenia gravis are reviewed, revealing the dominance of German physicians and neuropathologists in the early understanding of the disease. The development in pathology, aetiology, and therapy in the first half of the 20th century are described.

Entities:  

Mesh:

Year:  2005        PMID: 16289896     DOI: 10.1016/j.nmd.2005.08.007

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

1.  Commentary on "Randomized trial of thymectomy in myasthenia gravis".

Authors:  Alexandar Tzankov
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 2.  Pain, Headache, and Other Non-motor Symptoms in Myasthenia Gravis.

Authors:  Olivia Tong; Leslie Delfiner; Steven Herskovitz
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

Review 3.  History of Myasthenia Gravis Revisited.

Authors:  Feza Deymeer
Journal:  Noro Psikiyatr Ars       Date:  2020-11-07       Impact factor: 1.339

4.  Samuel Goldflam (1852-1932).

Authors:  Andrzej Grzybowski; Jarosław Sak
Journal:  J Neurol       Date:  2012-03-29       Impact factor: 4.849

5.  Myasthenia gravis: a review.

Authors:  Annapurni Jayam Trouth; Alok Dabi; Noha Solieman; Mohankumar Kurukumbi; Janaki Kalyanam
Journal:  Autoimmune Dis       Date:  2012-10-31

Review 6.  From toxins targeting ligand gated ion channels to therapeutic molecules.

Authors:  Adak Nasiripourdori; Valérie Taly; Thomas Grutter; Antoine Taly
Journal:  Toxins (Basel)       Date:  2011-03-21       Impact factor: 4.546

Review 7.  The Structure of Human Neuromuscular Junctions: Some Unanswered Molecular Questions.

Authors:  Clarke R Slater
Journal:  Int J Mol Sci       Date:  2017-10-19       Impact factor: 5.923

8.  Immune System Sex Differences May Bridge the Gap Between Sex and Gender in Fibromyalgia.

Authors:  Irene Meester; Gerardo Francisco Rivera-Silva; Francisco González-Salazar
Journal:  Front Neurosci       Date:  2020-01-17       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.